-
1
-
-
84868516062
-
Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia
-
Zaki A.M., van B.S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012, 367:1814-1820.
-
(2012)
N Engl J Med
, vol.367
, pp. 1814-1820
-
-
Zaki, A.M.1
van, B.S.2
Bestebroer, T.M.3
Osterhaus, A.D.4
Fouchier, R.A.5
-
2
-
-
84883105254
-
Middle East respiratory syndrome coronavirus infections in health care workers
-
Memish Z.A., Zumla A.I., Assiri A. Middle East respiratory syndrome coronavirus infections in health care workers. N Engl J Med 2013, 369:884-886.
-
(2013)
N Engl J Med
, vol.369
, pp. 884-886
-
-
Memish, Z.A.1
Zumla, A.I.2
Assiri, A.3
-
3
-
-
84880088201
-
Hospital outbreak of Middle East respiratory syndrome coronavirus
-
Assiri A., McGeer A., Perl T.M., Price C.S., Al Rabeeah A.A., Cummings D.A., et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 2013, 369:407-416.
-
(2013)
N Engl J Med
, vol.369
, pp. 407-416
-
-
Assiri, A.1
McGeer, A.2
Perl, T.M.3
Price, C.S.4
Al Rabeeah, A.A.5
Cummings, D.A.6
-
4
-
-
0344395657
-
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
-
Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003, 426:450-454.
-
(2003)
Nature
, vol.426
, pp. 450-454
-
-
Li, W.1
Moore, M.J.2
Vasilieva, N.3
Sui, J.4
Wong, S.K.5
Berne, M.A.6
-
5
-
-
84874996988
-
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
-
Raj V.S., Mou H., Smits S.L., Dekkers D.H., Muller M.A., Dijkman R., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013, 495:251-254.
-
(2013)
Nature
, vol.495
, pp. 251-254
-
-
Raj, V.S.1
Mou, H.2
Smits, S.L.3
Dekkers, D.H.4
Muller, M.A.5
Dijkman, R.6
-
6
-
-
84877339392
-
The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies
-
Gierer S., Bertram S., Kaup F., Wrensch F., Heurich A., Kramer-Kuhl A., et al. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol 2013, 87:5502-5511.
-
(2013)
J Virol
, vol.87
, pp. 5502-5511
-
-
Gierer, S.1
Bertram, S.2
Kaup, F.3
Wrensch, F.4
Heurich, A.5
Kramer-Kuhl, A.6
-
7
-
-
84872146295
-
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines
-
Muller M.A., Raj V.S., Muth D., Meyer B., Kallies S., Smits S.L., et al. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio 2012, 3.
-
(2012)
MBio
, pp. 3
-
-
Muller, M.A.1
Raj, V.S.2
Muth, D.3
Meyer, B.4
Kallies, S.5
Smits, S.L.6
-
8
-
-
84877262971
-
Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation
-
Chan J.F., Chan K.H., Choi G.K., To K.K., Tse H., Cai J.P., et al. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis 2013, 207:1743-1752.
-
(2013)
J Infect Dis
, vol.207
, pp. 1743-1752
-
-
Chan, J.F.1
Chan, K.H.2
Choi, G.K.3
To, K.K.4
Tse, H.5
Cai, J.P.6
-
9
-
-
35548966062
-
Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses
-
Bai B., Lu X., Meng J., Hu Q., Mao P., Lu B., et al. Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses. Mol Immunol 2008, 45:868-875.
-
(2008)
Mol Immunol
, vol.45
, pp. 868-875
-
-
Bai, B.1
Lu, X.2
Meng, J.3
Hu, Q.4
Mao, P.5
Lu, B.6
-
10
-
-
70349383960
-
Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
-
Du L., Zhao G., Chan C.C., Sun S., Chen M., Liu Z., et al. Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity. Virology 2009, 393:144-150.
-
(2009)
Virology
, vol.393
, pp. 144-150
-
-
Du, L.1
Zhao, G.2
Chan, C.C.3
Sun, S.4
Chen, M.5
Liu, Z.6
-
11
-
-
17044375920
-
Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies
-
He Y., Lu H., Siddiqui P., Zhou Y., Jiang S. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J Immunol 2005, 174:4908-4915.
-
(2005)
J Immunol
, vol.174
, pp. 4908-4915
-
-
He, Y.1
Lu, H.2
Siddiqui, P.3
Zhou, Y.4
Jiang, S.5
-
12
-
-
40449085104
-
Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection
-
Du L., Zhao G., Lin Y., Sui H., Chan C., Ma S., et al. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. J Immunol 2008, 180:948-956.
-
(2008)
J Immunol
, vol.180
, pp. 948-956
-
-
Du, L.1
Zhao, G.2
Lin, Y.3
Sui, H.4
Chan, C.5
Ma, S.6
-
13
-
-
33645796224
-
Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice
-
Lee J.S., Poo H., Han D.P., Hong S.P., Kim K., Cho M.W., et al. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J Virol 2006, 80:4079-4087.
-
(2006)
J Virol
, vol.80
, pp. 4079-4087
-
-
Lee, J.S.1
Poo, H.2
Han, D.P.3
Hong, S.P.4
Kim, K.5
Cho, M.W.6
-
14
-
-
60749134643
-
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
-
Du L., He Y., Zhou Y., Liu S., Zheng B.J., Jiang S. The spike protein of SARS-CoV - a target for vaccine and therapeutic development. Nat Rev Microbiol 2009, 7:226-236.
-
(2009)
Nat Rev Microbiol
, vol.7
, pp. 226-236
-
-
Du, L.1
He, Y.2
Zhou, Y.3
Liu, S.4
Zheng, B.J.5
Jiang, S.6
-
15
-
-
84886007720
-
Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus
-
Chen Y., Rajashankar K.R., Yang Y., Agnihothram S.S., Liu C., Lin Y.L., et al. Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus. J Virol 2013, 87:10777-10783.
-
(2013)
J Virol
, vol.87
, pp. 10777-10783
-
-
Chen, Y.1
Rajashankar, K.R.2
Yang, Y.3
Agnihothram, S.S.4
Liu, C.5
Lin, Y.L.6
-
16
-
-
84881232247
-
The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies
-
Mou H., Raj V.S., van Kuppeveld F.J., Rottier P.J., Haagmans B.L., Bosch B.J. The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol 2013, 87:9379-9383.
-
(2013)
J Virol
, vol.87
, pp. 9379-9383
-
-
Mou, H.1
Raj, V.S.2
van Kuppeveld, F.J.3
Rottier, P.J.4
Haagmans, B.L.5
Bosch, B.J.6
-
17
-
-
84881190964
-
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
-
Wang N., Shi X., Jiang L., Zhang S., Wang D., Tong P., et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res 2013, 23:986-993.
-
(2013)
Cell Res
, vol.23
, pp. 986-993
-
-
Wang, N.1
Shi, X.2
Jiang, L.3
Zhang, S.4
Wang, D.5
Tong, P.6
-
18
-
-
84886875619
-
Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development
-
Du L., Zhao G., Kou Z., Ma C., Sun S., Poon V.K., et al. Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development. J Virol 2013, 87:9939-9942.
-
(2013)
J Virol
, vol.87
, pp. 9939-9942
-
-
Du, L.1
Zhao, G.2
Kou, Z.3
Ma, C.4
Sun, S.5
Poon, V.K.6
-
19
-
-
84880641719
-
A recombinant protein containing highly conserved hemagglutinin residues 81-122 of influenza H5N1 induces strong humoral and mucosal immune responses
-
Li Y., Du L., Qiu H., Zhao G., Wang L., Zhou Y., et al. A recombinant protein containing highly conserved hemagglutinin residues 81-122 of influenza H5N1 induces strong humoral and mucosal immune responses. Biosci Trends 2013, 7:129-137.
-
(2013)
Biosci Trends
, vol.7
, pp. 129-137
-
-
Li, Y.1
Du, L.2
Qiu, H.3
Zhao, G.4
Wang, L.5
Zhou, Y.6
-
20
-
-
33947189535
-
Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
-
Du L., Zhao G., He Y., Guo Y., Zheng B.J., Jiang S., et al. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model. Vaccine 2007, 25:2832-2838.
-
(2007)
Vaccine
, vol.25
, pp. 2832-2838
-
-
Du, L.1
Zhao, G.2
He, Y.3
Guo, Y.4
Zheng, B.J.5
Jiang, S.6
-
21
-
-
5144234050
-
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
-
He Y., Zhou Y., Liu S., Kou Z., Li W., Farzan M., et al. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun 2004, 324:773-781.
-
(2004)
Biochem Biophys Res Commun
, vol.324
, pp. 773-781
-
-
He, Y.1
Zhou, Y.2
Liu, S.3
Kou, Z.4
Li, W.5
Farzan, M.6
-
22
-
-
84872190107
-
A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection
-
Du L., Zhao G., Sun S., Zhang X., Zhou X., Guo Y., et al. A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection. PLoS ONE 2013, 8:e53568.
-
(2013)
PLoS ONE
, vol.8
-
-
Du, L.1
Zhao, G.2
Sun, S.3
Zhang, X.4
Zhou, X.5
Guo, Y.6
-
23
-
-
67651204591
-
Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors
-
Martyn J.C., Cardin A.J., Wines B.D., Cendron A., Li S., Mackenzie J., et al. Surface display of IgG Fc on baculovirus vectors enhances binding to antigen-presenting cells and cell lines expressing Fc receptors. Arch Virol 2009, 154:1129-1138.
-
(2009)
Arch Virol
, vol.154
, pp. 1129-1138
-
-
Martyn, J.C.1
Cardin, A.J.2
Wines, B.D.3
Cendron, A.4
Li, S.5
Mackenzie, J.6
-
24
-
-
34250614327
-
Immunogenicity of the outer domain of a HIV-1 clade C gp120
-
Chen H., Xu X., Jones I.M. Immunogenicity of the outer domain of a HIV-1 clade C gp120. Retrovirology 2007, 4:33.
-
(2007)
Retrovirology
, vol.4
, pp. 33
-
-
Chen, H.1
Xu, X.2
Jones, I.M.3
-
25
-
-
84891885053
-
A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines
-
Du L., Kou Z., Ma C., Tao X., Wang L., Zhao G., et al. A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines. PLoS ONE 2013, 8:e81587.
-
(2013)
PLoS ONE
, vol.8
-
-
Du, L.1
Kou, Z.2
Ma, C.3
Tao, X.4
Wang, L.5
Zhao, G.6
-
26
-
-
40249111494
-
Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection
-
Du L., Zhao G., Lin Y., Chan C., He Y., Jiang S., et al. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine 2008, 26:1644-1651.
-
(2008)
Vaccine
, vol.26
, pp. 1644-1651
-
-
Du, L.1
Zhao, G.2
Lin, Y.3
Chan, C.4
He, Y.5
Jiang, S.6
-
27
-
-
84883262923
-
Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells
-
Tao X., Hill T.E., Morimoto C., Peters C.J., Ksiazek T.G., Tseng C.T. Bilateral entry and release of Middle East respiratory syndrome coronavirus induces profound apoptosis of human bronchial epithelial cells. J Virol 2013, 87:9953-9958.
-
(2013)
J Virol
, vol.87
, pp. 9953-9958
-
-
Tao, X.1
Hill, T.E.2
Morimoto, C.3
Peters, C.J.4
Ksiazek, T.G.5
Tseng, C.T.6
-
28
-
-
84879041188
-
Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart
-
Cauchemez S., Van K.M., Riley S., Donnelly C., Fraser C., Ferguson N. Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill 2013, 18.
-
(2013)
Euro Surveill
, pp. 18
-
-
Cauchemez, S.1
Van, K.M.2
Riley, S.3
Donnelly, C.4
Fraser, C.5
Ferguson, N.6
-
29
-
-
84882918127
-
Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
-
Breban R., Riou J., Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 2013, 382:694-699.
-
(2013)
Lancet
, vol.382
, pp. 694-699
-
-
Breban, R.1
Riou, J.2
Fontanet, A.3
-
30
-
-
84887148359
-
Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate
-
Almazan F., DeDiego M.L., Sola I., Zuniga S., Nieto-Torres J.L., Marquez-Jurado S., et al. Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. MBio 2013, 4:e00650-e713.
-
(2013)
MBio
, vol.4
-
-
Almazan, F.1
DeDiego, M.L.2
Sola, I.3
Zuniga, S.4
Nieto-Torres, J.L.5
Marquez-Jurado, S.6
-
31
-
-
65649110128
-
Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells
-
Du L., Zhao G., Li L., He Y., Zhou Y., Zheng B.J., et al. Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells. Biochem Biophys Res Commun 2009, 384:486-490.
-
(2009)
Biochem Biophys Res Commun
, vol.384
, pp. 486-490
-
-
Du, L.1
Zhao, G.2
Li, L.3
He, Y.4
Zhou, Y.5
Zheng, B.J.6
-
32
-
-
84869081784
-
Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?
-
Chan J.F., Li K.S., To K.K., Cheng V.C., Chen H., Yuen K.Y. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?. J Infect 2012, 65:477-489.
-
(2012)
J Infect
, vol.65
, pp. 477-489
-
-
Chan, J.F.1
Li, K.S.2
To, K.K.3
Cheng, V.C.4
Chen, H.5
Yuen, K.Y.6
-
33
-
-
84881553690
-
Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans
-
e00473-12
-
van B.S., de G.M., Lauber C., Bestebroer T.M., Raj V.S., Zaki A.M., et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 2012, 3:e00473-12.
-
(2012)
MBio
, vol.3
-
-
van, B.S.1
de, G.M.2
Lauber, C.3
Bestebroer, T.M.4
Raj, V.S.5
Zaki, A.M.6
-
34
-
-
84886937421
-
Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus ankara efficiently induces virus-neutralizing antibodies
-
Song F., Fux R., Provacia L.B., Volz A., Eickmann M., Becker S., et al. Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus ankara efficiently induces virus-neutralizing antibodies. J Virol 2013, 87:11950-11954.
-
(2013)
J Virol
, vol.87
, pp. 11950-11954
-
-
Song, F.1
Fux, R.2
Provacia, L.B.3
Volz, A.4
Eickmann, M.5
Becker, S.6
-
35
-
-
13944257660
-
Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection
-
Ichinohe T., Watanabe I., Ito S., Fujii H., Moriyama M., Tamura S., et al. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. J Virol 2005, 79:2910-2919.
-
(2005)
J Virol
, vol.79
, pp. 2910-2919
-
-
Ichinohe, T.1
Watanabe, I.2
Ito, S.3
Fujii, H.4
Moriyama, M.5
Tamura, S.6
-
36
-
-
35148824709
-
Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge
-
Ichinohe T., Kawaguchi A., Tamura S., Takahashi H., Sawa H., Ninomiya A., et al. Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge. Microbes Infect 2007, 9:1333-1340.
-
(2007)
Microbes Infect
, vol.9
, pp. 1333-1340
-
-
Ichinohe, T.1
Kawaguchi, A.2
Tamura, S.3
Takahashi, H.4
Sawa, H.5
Ninomiya, A.6
-
37
-
-
84876698358
-
Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011-2012 influenza vaccine season
-
Frasca D., Diaz A., Romero M., Mendez N.V., Landin A.M., Blomberg B.B. Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011-2012 influenza vaccine season. Immun Ageing 2013, 10:14.
-
(2013)
Immun Ageing
, vol.10
, pp. 14
-
-
Frasca, D.1
Diaz, A.2
Romero, M.3
Mendez, N.V.4
Landin, A.M.5
Blomberg, B.B.6
-
38
-
-
84880053841
-
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission
-
Guery B., Poissy J., El M.L., Sejourne C., Ettahar N., Lemaire X., et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet 2013, 381:2265-2272.
-
(2013)
Lancet
, vol.381
, pp. 2265-2272
-
-
Guery, B.1
Poissy, J.2
El, M.L.3
Sejourne, C.4
Ettahar, N.5
Lemaire, X.6
-
39
-
-
84882614929
-
Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection
-
Drosten C., Seilmaier M., Corman V.M., Hartmann W., Scheible G., Sack S., et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 2013, 13:745-751.
-
(2013)
Lancet Infect Dis
, vol.13
, pp. 745-751
-
-
Drosten, C.1
Seilmaier, M.2
Corman, V.M.3
Hartmann, W.4
Scheible, G.5
Sack, S.6
-
40
-
-
77956478136
-
CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein
-
Zhao K., Yang B., Xu Y., Wu C. CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein. Vaccine 2010, 28:6666-6674.
-
(2010)
Vaccine
, vol.28
, pp. 6666-6674
-
-
Zhao, K.1
Yang, B.2
Xu, Y.3
Wu, C.4
-
41
-
-
67651235728
-
Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection
-
Fan Y.Y., Huang Z.T., Li L., Wu M.H., Yu T., Koup R.A., et al. Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection. Arch Virol 2009, 154:1093-1099.
-
(2009)
Arch Virol
, vol.154
, pp. 1093-1099
-
-
Fan, Y.Y.1
Huang, Z.T.2
Li, L.3
Wu, M.H.4
Yu, T.5
Koup, R.A.6
-
42
-
-
33646894897
-
Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses
-
Huang J., Ma R., Wu C.Y. Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses. Vaccine 2006, 24:4905-4913.
-
(2006)
Vaccine
, vol.24
, pp. 4905-4913
-
-
Huang, J.1
Ma, R.2
Wu, C.Y.3
-
43
-
-
84855170210
-
A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen
-
Kakimi K., Isobe M., Uenaka A., Wada H., Sato E., Doki Y., et al. A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen. Int J Cancer 2011, 129:2836-2846.
-
(2011)
Int J Cancer
, vol.129
, pp. 2836-2846
-
-
Kakimi, K.1
Isobe, M.2
Uenaka, A.3
Wada, H.4
Sato, E.5
Doki, Y.6
-
44
-
-
84866547636
-
Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor
-
Do Y., Didierlaurent A.M., Ryu S., Koh H., Park C.G., Park S., et al. Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor. Vaccine 2012, 30:6359-6367.
-
(2012)
Vaccine
, vol.30
, pp. 6359-6367
-
-
Do, Y.1
Didierlaurent, A.M.2
Ryu, S.3
Koh, H.4
Park, C.G.5
Park, S.6
|